Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Crescent Pharma is a leading independent generic pharmaceutical company based in the United Kingdom, established in 2003. The company specializes in the development, licensing, and distribution of a broad portfolio of over 300 generic medicines across various therapeutic areas, including cardiovascular, neurology, and gastroenterology. Operating through its export arm, Crescent International, the company serves a global market while remaining a key supplier to the UK National Health Service (NHS). Crescent Pharma maintains extensive manufacturing and distribution capabilities, providing a wide range of dosage forms such as tablets, capsules, and liquids. The company is recognized for its robust supply chain and commitment to providing affordable healthcare solutions globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Crescent International.